Qiagen NV | QIA - 营业利润

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.31B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	营业利润	更改		日
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.01M		175K	2026-03
argenx SE	USD 493M		99M	2026-06
Avita Medical	AUD -10.41M		742K	2025-12
Dianthus Therapeutics	USD -46.53M		23.01M	2026-03
Ionis Pharmaceuticals	USD -102.29M		15.71M	2026-06
IQVIA Holdings	USD 2.6B		2.03B	2026-06
Moderna	USD -815M		573M	2026-06
Organon & Co	USD 323M		57M	2026-06
Qiagen NV	USD 141.4M		24.77M	2026-06
Revvity	USD 126.14M		43.36M	2026-06
Tectonic Therapeutic	USD -27.3M		5.78M	2026-03
Viatris	USD 73.7M		93.9M	2026-06
Xeris Pharmaceuticals	USD 7.92M		8.86M	2026-03